AUPH
AUPH
NASDAQ · Biotechnology

Aurinia Pharmaceuticals Inc

$14.41
+0.20 (+1.41%)
As of Mar 25, 1:35 PM ET ·
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Buy 9 69%
Hold 4 31%
Sell 0 0%
Price Target
Analyst Price Target +182.0% upside
Low Target $34.07
Average Target $40.64
High Target $61.77
Current Price $14.41
Current
$14.41
Target
$40.64
$34.07 $40.64 avg $61.77
Scenario Analysis
Bear Case
$34.07
136.4%
Low target
Base Case
$40.64
+182.0%
Avg target
Bull Case
$61.77
+328.7%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$16.54
-12.9% from high
52-Week Low
$6.83
+111.1% from low
Target vs 52W High
$40.64
+145.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%